Comparative cost models of a liquid nitrogen vapor phase (LNVP) cold chain-distributed cryopreserved malaria vaccine vs. a conventional vaccine

Vaccine

Volumn 31, Issue 2, 2013, Pages 380-386

  Garcia, Cristina Reyes ^a   Manzi, Fatuma ^b   Tediosi, Fabrizio ^c   Hoffman, Stephen L ^d   James, Eric R ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d SANARIA INC   (United States)

Author keywords

Cold chain; Distribution cost; Liquid nitrogen vapor phase; Malaria; Model; Vaccine

Indexed keywords

LIQUID NITROGEN; MALARIA VACCINE;

ARTICLE; COHORT ANALYSIS; COLD; CRYOPRESERVATION; DRUG STORAGE; ENERGY COST; HEALTH CARE COST; HEALTH CARE FACILITY; IMMUNIZATION; LIQUID NITROGEN VAPOR PHASE COLD CHAIN; PRIORITY JOURNAL; TANZANIA; TRAFFIC AND TRANSPORT;

CRYOPRESERVATION; DRUG STORAGE; HEALTH FACILITIES; MALARIA VACCINES; NITROGEN; REFRIGERATION; TANZANIA;

EID: 84871396047     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.109     Document Type: Article

References (46)

1. Hoffman S.L., Billingsley P.F., James E.R., Richman A., Loyevsky M., Li T., et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccine 2010, 38:97-106.
2. World Health Organization. Expanded Programme on Immunization (EPI). http://who.int/immunization_delivery/en/.
3. World Health Organization. (WHO/EPI/TRAM/98.02 REV.1, Module 2: EPI vaccines). http://whqlibdoc.who.int/hq/1998/WHO_EPI_TRAM_98.02.pdf.
4. International AIDS Vaccine Initiative, PATH HPV vaccine adoption in developing countries: cost and financing issues 2007, http://screening.iarc.fr/doc/IAVI_PATH_HPV_financing.pdf.
5. Maire N., Shillcutt S.D., Walker D.G., Tediosi F., Smith T.A. Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria. Value Health 2011, 8:1028-1038.
6. Clemens J., Jodar L. Introducing new vaccines into developing countries: obstacles, opportunities and complexities. Nat Med 2005, 11:S12-S15.
7. PATH Summary of stability data for commonly used vaccines and novel vaccine formulations 2008, PATH Vaccine Stabilization Team. http://www.path.org/publications/files/TS_vaccine_stability_table.pdf.
8. World Health Organization. Immunization service delivery: Project Optimize. http://www.who.int/immunization_delivery/optimize/en/index.html.
9. World Health Organization. Guidelines for establishing or improving national, regional and district vaccine stores (WHO/EPI/LHIS/96.03). http://whqlibdoc.who.int/hq/1996/WHO_EPI_LHIS_96.03.pdf.
10. World Health Organization. Guideline for establishing or improving primary and intermediate vaccine stores. (WHO/V&B/02.34). http://www.who.int/vaccines-documents/DocsPDF02/www715.pdf.
11. UNICEF, Supplies and logistics: vaccine price data, Pneumoccocal vaccine. http://www.unicef.org/supply/index_60990.html%3Fp=printme.
12. WHO Optimize Project in Tunisia 2010-2012, Collaborative agreement between WHO Tunisia and the Ministry of Public Health, project proposal. http://www.who.int/immunization_delivery/systems_policy/Tunisia_Optimize_ProjectProposal_15Jan10_EN.pdf.
13. World Health Organization EPI logistics: cold chain 2009, Available from: http://www.unicef.org/immunization/files/CCL_Workshop_Report_Nov_2009.pdf [cited 23.09.09].
14. Weir E., Hatch K. Preventing cold chain failure: vaccine storage and handling. CMAJ 2004, 171:1050.
15. Berhane Y., Demissie M. Cold chain status at immunisation centres in Ethiopia. East Afr Med J 2000, 77:476-479.
16. Simba D.O., Msamanga G.I. Use of cold-chain to assess vaccine exposure to adverse temperatures in rural Tanzania. East Afr Med J 1994, 71:445-446.
17. Matthias D.M., Robertson J., Garrison M.M., Newland S., Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine 2007, 25:3980-3986.
18. Techathawat S., Varinsathien P., Rasdjarmrearnsook A., Tharmaphornpilas P. Exposure to heat and freezing in the vaccine cold chain in Thailand. Vaccine 2007, 25:1328-1333.
19. World Health Organization Temperature sensitivity of vaccines 2006, http://www.who.int/vaccines-documents/DocsPDF06/847.pdf.
20. PATH 2009-2012 Optimize strategy 2009, http://www.who.int/immunization_delivery/systems_policy/Optimize_Strategy_2009-2012.pdf.
21. Dicko M. Supply chain integration. Cold chain and logistics management meeting 2009, http://www.technet21.org/Technet_forum/Immunization_Newsletter2010/Dec_12_2010/5_Integration_Presentation_Technet_02Dec10.ppt.
22. Centers for Disease Control and Prevention. Vaccine management business improvement project. http://www.cdc.gov/vaccines/programs/vmbip/default.htm.
23. Centers for Disease Control and Prevention The pink book: epidemiology and prevention of vaccine preventable diseases 2011, http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/vac-storage.pdf [chapter 5, Vaccine storage and handling]. 12th ed.
24. 2) cold-chain for malaria vaccine distribution in Africa 2008, http://www.who.int/vaccine_research/documents/Lee_LN_Infrastructure_in_Africa_MalVac_00_.pdf [cited in: Pinder et al., 2010, MALVAC 2009: Progress and challenges in Development of whole organism malaria vaccines for endemic countries, 3-4 June 2009, Dakar, Senegal. Vaccine 28: 4695-4702].
25. Hutton G., Tediosi F. The costs of introducing a malaria vaccine through the expanded program on immunization in Tanzania. Am J Trop Med Hyg 2006, 75(2 Suppl):119-130.
26. Meussen E.N.T., Walker J., Peters A., Pastoret P.-P., Jungersen G. Current status of veterinary vaccines. Clin Microbiol 2007, 20:489-510.
27. Hasler J.F. The current status and future of commercial embryo transfer in cattle. Anim Reprod Sci 2003, 79:245-264.
28. Hiemstra S.J., van der Lende T., Woelders H. The potential of cryopreservation and reproductive technologies for animal genetics resources conservation strategies 2005, http://www.fao.org/biotech/docs/hiemstra.pdf.
29. Westermann J., Körner I.J., Kopp J., Zenke S., Dörken B., Pezzutto A. Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties. Cancer Immunol Immunother 2003, 52:194-198.
30. Liseth K., Ersvaer E., Hervig T., Bruserud Ø. Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience. J Biomed Biotech 2010, Article ID 692097. 10.1155/2010/692097.
31. Di Giulio G., Lynen G., Morzaria S., Oura C., Bishop R. Live immunization against East Coast fever - current status. Trends Parasitol 2009, 25:85-92.
32. Management Sciences for Health Managing drug supply 1997, Kumarian Press, USA.
33. World Health Organization Vaccine volume calculator in cold chain and logistics tools 2009, http://www.who.int/immunization_delivery/systems_policy/logistics/en/index4.html.
34. World Health Organization Logistics planning tool in cold chain and logistics tools 2009, http://www.who.int/immunization_delivery/systems_policy/logistics/en/index5.html.
35. World Health Organization Vaccine management and logistics: vaccine forecast and needs estimation 2010, http://www.who.int/immunization_delivery/systems_policy/logistics/en/index2.html.
36. World Health Organization. New Product Information Sheets (PIS) since 2000 edition. http://www.who.int/immunization_standards/vaccine_quality/new_sheets_intro/en/index.html.
37. Medical Stores Department Medical Stores Department Tanzania 2002-2010, Available from: http://www.msd.or.tz/ [cited 2009].
38. National Bureau of Statistics: United Republic of Tanzania, Tanzania. Statistics for development. http://www.tanzania.go.tz/nbsf.html.
39. Manzi F, Ifakara Research and Development Centre, Ifakara, Tanzania. February 2011.
40. World Bank. 2011 World Development Indicators, 2.1 Population Dynamics. http://data.worldbank.org/country/tanzania.
41. World Health Organization Monitoring vaccine wastage at country level 2003, http://whqlibdoc.who.int/hq/2005/WHO_V&B_03.18.Rev.1_eng.pdf (WHO/V&B/03.18).
42. World Health Organization Immunization service delivery and accelerated disease control: projected vaccine wastage 2011, http://www.who.int/immunization_delivery/systems_policy/logistics_projected_wastage/en/index.html.
43. TANESCO; 2009, Available from: http://www.tanesco.co.tz/.
44. Kagaruki K. Summary of District Transport Monthly Budgets 2002/2003. 2009, Expanded Program on Immunizations Tanzania.
45. Pinder M., Moorthy V.S., Akanmori B.D., Genton B., Brown G.V. MALVAC 2009 Progress and challenges in development of whole organism malaria vaccines for endemic countries, 3-4 June 2009, Dakar, Senegal. Vaccine 2010, 28:4695-4702.
46. + T cell immunity. Science 2011, 334:475-480.